Keyphrases
Transintestinal Cholesterol Excretion
100%
Farnesoid X Receptor
100%
Cholesterol
85%
Bile Salts
57%
Bile
57%
Fibroblast Growth Factor 19 (FGF19)
42%
Intestine
28%
Cholesterol Absorption
28%
Intestine-specific
28%
Fgf15
28%
Hydrophilicity
14%
Wistar Rats
14%
Drinking Water
14%
Intravenous Injection
14%
AIMS™
14%
Knock-in Mouse Model
14%
Biliary Cholesterol Secretion
14%
Intestinal Lumen
14%
ATP-binding Cassette Transporter A1 (ABCA1)
14%
Cholesterol Synthesis
14%
Control Diet
14%
Fecal Excretion
14%
Sterols
14%
Reverse Cholesterol Transport
14%
Acetate
14%
Cholesterol Levels
14%
Bile Duct
14%
Cardiovascular Prevention
14%
Transport Pathway
14%
Secretion Rate
14%
Cholesterol Absorption Inhibitor
14%
Ezetimibe
14%
Cholesterol Homeostasis
14%
Cannulation
14%
Cholate
14%
Cholesterol Removal
14%
ABCG8
14%
ABCG5
14%
Atheroprotective Effects
14%
Member 5
14%
Medicine and Dentistry
Farnesoid X Receptor
100%
Intestine
57%
Bile
57%
Bile Salt
57%
Fibroblast Growth Factor 19
42%
Secretion (Process)
28%
Homeostasis
14%
Cardiovascular Disease
14%
Cholesterol Transport
14%
Transgene
14%
Intravenous Drug Administration
14%
Bile Duct
14%
Cannulation
14%
Acetic Acid
14%
Cholic Acid
14%
Heterodimer
14%
Sterol
14%
Cholesterol Synthesis
14%
Cholesterol Absorption Inhibitor
14%
Ezetimibe
14%
ABC Transporter Subfamily G
14%
Biochemistry, Genetics and Molecular Biology
Mouse
100%
Farnesoid X Receptor
100%
Absorption
27%
FGF19
27%
Secretion (Process)
18%
Homeostasis
9%
Adenosine Triphosphate
9%
Transgene
9%
Wistar Rat
9%
Receptor Agonists
9%
Sterol
9%
Cholesterol Synthesis
9%
Cholesterol Blood Level
9%
Knockout Mouse
9%
Reverse Cholesterol Transport
9%
Hydrophilicity
9%
ABCG8
9%
ABCG5
9%
FGF15
9%